Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US

Journal of Gastrointestinal Surgery

Volumn 17, Issue 9, 2013, Pages 1600-1608

  Stacy, Sylvie ^a   Hyder, Omar ^a   Cosgrove, David ^a   Herman, Joseph M ^a   Kamel, Ihab ^a   Geschwind, Jean Francois H ^a   Gurakar, Ahmet ^a   Anders, Robert ^a   Cameron, Andrew ^a   Pawlik, Timothy M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Carcinoma; Consultation; Hepatocellular; Referral patterns

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CLINICAL PRACTICE; EVALUATION STUDY; FEMALE; GASTROENTEROLOGY; GENERAL SURGERY; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; ONCOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; GASTROENTEROLOGY; GENERAL SURGERY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MARYLAND; MEDICAL ONCOLOGY; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PROPORTIONAL HAZARDS MODELS; RADIOLOGY, INTERVENTIONAL; REFERRAL AND CONSULTATION; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84883221249     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2253-y     Document Type: Article

References (30)

1. Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3): 1020-2.
2. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2S88-94.
3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the US from 1975 to 2005. J Clin Oncol. 2009;27(9): 1485-91.
4. Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005;23(13): 2892-9.
5. Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, Wolfgang CL, Segev DL, Choti MA, Pawlik TM. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29(6): 619-25.
6. Nathan H, Segev DL, Bridges JF, Massie AB, Cameron AM, Hirose K, Schulick RD, Choti MA, Pawlik TM. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol. 2013;20(2): 448-56.
7. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Hepatobiliary Cancers. Version 2. 2012.
8. El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. Journal of Hepatology. 2006;44(1): 158-166.
9. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35(3): 519-24.
10. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Public Use, Nov. 2010 Sub (2000-2008)-Linked to County Attributes-Total US, 1969-2008 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2011.
11. Nathan H, Hyder O, Mayo SC, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Surgical Therapy for Early Hepatocellular Carcinoma in the Modern Era: A 10-Year SEER-Medicare Analysis. Ann Surg. 2013.
12. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Medical Care. 2009;47(6): 626-633.
13. Reynolds GA, Chitnis JG, Roland MO. General practitioner outpatient referrals: do good doctors refer more patients to hospital? BMJ. 1991;302(6787): 1250-2.
14. Franks P, Clancy CM. Referrals of adult patients from primary care: demographic disparities and their relationship to HMO insurance. J Fam Pract. 1997;45(1): 47-53.
15. Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007;25(17): 2389-96.
16. Mandl LA. Determining who should be referred for total hip and knee replacements. Nat Rev Rheumatol. 2013.
17. Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ. Referral Patterns for Patients with High-Risk Thyroid Cancer. Endocrine Practice. 2013;1-19.
18. Zhang J, Mavros MN, Cosgrove D, Hirose K, Herman JM, Smallwood-Massey S, Karnel I, Gurakar A, Anders R, Cameron A. Impact of a single-day multidisciplinary clinic on the management of patients with liver tumors. Current Oncology. 2013;20(2): e123.
19. Cance WG, Stewart AK, Menck HR. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996. Cancer. 2000;88(4): 912-20.
20. Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Vern Davenport RL Girgus M, Ronarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW. The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011;123(19): 2167-79.
21. Facility Oncology Registry Data Standards. Chicago, IL: Commission on Cancer. 2012.
22. Gliklich R, Dreyer N. Registries for Evaluating Patient Outcomes. Agency for Healthcare Research and Quality, Rockville, MD. 2010.
23. Kurtz JE, Heitz D, Enderlin P, Imbert F, Nehme H, Bergerat JP, Dufour P. Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol Hematol. 2010;75(1): 47-57.
24. Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer. 2011;117(5): 1019-26.
25. Nathan H, Frederick W, Choti MA, Schulick RD, Pawlik TM. Racial disparity in surgical mortality after major hepatectomy. J Am Coll Surgeons. 2008;207(3): 312-319.
26. Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K. Race and Colon Cancer Survival in an Equal-Access Healthcare System. Cancer Epidem Biomar. 2013.
27. Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer. Support Care Cancer. 2013;1-9.
28. Del Carmen MG, Avila-Wallace M. Effect of Health Care Disparities on Screening. Clin Obstet Gynecol. 2013;56(1): 65-75.
29. Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109(5): 975-82.
30. Kirkpatrick HM, Aitelli CL, Qin H, Becerra C, Lichliter WE, McCollum AD. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Clin Colorectal Cancer. 2010;9(3): 150-6.